[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

HK1199891A1 - 用於克隆和表達關聯抗體可變區基因區段的快速方法 - Google Patents

用於克隆和表達關聯抗體可變區基因區段的快速方法

Info

Publication number
HK1199891A1
HK1199891A1 HK15100396.3A HK15100396A HK1199891A1 HK 1199891 A1 HK1199891 A1 HK 1199891A1 HK 15100396 A HK15100396 A HK 15100396A HK 1199891 A1 HK1199891 A1 HK 1199891A1
Authority
HK
Hong Kong
Prior art keywords
cloning
expression
variable region
gene segments
antibody variable
Prior art date
Application number
HK15100396.3A
Other languages
English (en)
Inventor
Simone Hoege
Erhard Kopetzki
Dominique Ostler
Stefan Seeber
Georg Tiefenthaler
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=47522537&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HK1199891(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of HK1199891A1 publication Critical patent/HK1199891A1/zh

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/10Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1034Isolating an individual clone by screening libraries
    • C12N15/1086Preparation or screening of expression libraries, e.g. reporter assays
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06Animal cells or tissues; Human cells or tissues
    • C12N5/0602Vertebrate cells
    • C12N5/0634Cells from the blood or the immune system
    • C12N5/0635B lymphocytes
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00Preparation of peptides or proteins
    • C12P21/02Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2317/00Immunoglobulins specific features
    • C07K2317/10Immunoglobulins specific features characterized by their source of isolation or production
    • C07K2317/14Specific host cells or culture conditions, e.g. components, pH or temperature
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2317/00Immunoglobulins specific features
    • C07K2317/50Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/56Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2510/00Genetically modified cells
    • C12N2510/02Cells for production

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Medicinal Chemistry (AREA)
  • Hematology (AREA)
  • Cell Biology (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Analytical Chemistry (AREA)
HK15100396.3A 2011-12-21 2015-01-14 用於克隆和表達關聯抗體可變區基因區段的快速方法 HK1199891A1 (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP11194861 2011-12-21
PCT/EP2012/076155 WO2013092716A1 (en) 2011-12-21 2012-12-19 Rapid method for cloning and expression of cognate antibody variable region gene segments

Publications (1)

Publication Number Publication Date
HK1199891A1 true HK1199891A1 (zh) 2015-07-24

Family

ID=47522537

Family Applications (1)

Application Number Title Priority Date Filing Date
HK15100396.3A HK1199891A1 (zh) 2011-12-21 2015-01-14 用於克隆和表達關聯抗體可變區基因區段的快速方法

Country Status (12)

Country Link
US (3) US20140302559A1 (zh)
EP (1) EP2794652B1 (zh)
JP (3) JP2015500655A (zh)
KR (1) KR20140104963A (zh)
CN (2) CN104011074A (zh)
BR (1) BR112014013034A2 (zh)
CA (1) CA2854243A1 (zh)
HK (1) HK1199891A1 (zh)
MX (1) MX354049B (zh)
RU (1) RU2612910C2 (zh)
SG (1) SG11201403365TA (zh)
WO (1) WO2013092716A1 (zh)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2011010168A (es) 2009-04-07 2011-10-11 Roche Glycart Ag Anticuerpos biespecificos, trivalentes.
US9676845B2 (en) 2009-06-16 2017-06-13 Hoffmann-La Roche, Inc. Bispecific antigen binding proteins
RU2015153109A (ru) 2009-09-16 2019-01-15 Дженентек, Инк. Содержащие суперспираль и/или привязку белковые комплексы и их применения
TW201138821A (en) 2010-03-26 2011-11-16 Roche Glycart Ag Bispecific antibodies
JP5758004B2 (ja) 2010-08-24 2015-08-05 エフ.ホフマン−ラ ロシュ アーゲーF. Hoffmann−La Roche Aktiengesellschaft ジスルフィドによって安定化されたFv断片を含む二重特異性抗体
SG191153A1 (en) 2010-12-23 2013-07-31 Hoffmann La Roche Polypeptide-polynucleotide-complex and its use in targeted effector moiety delivery
KR101638224B1 (ko) 2011-02-28 2016-07-08 에프. 호프만-라 로슈 아게 항원 결합 단백질
KR101572338B1 (ko) 2011-02-28 2015-11-26 에프. 호프만-라 로슈 아게 1가 항원 결합 단백질
JP2015500655A (ja) * 2011-12-21 2015-01-08 エフ.ホフマン−ラ ロシュ アーゲーF. Hoffmann−La Roche Aktiengesellschaft 同起源の抗体可変領域遺伝子セグメントをクローニングおよび発現させるための迅速な方法
MX2014009565A (es) 2012-02-10 2014-11-10 Genentech Inc Anticuerpos monocatenarios y otros heteromultimeros.
MX2014014804A (es) 2012-06-27 2015-02-12 Hoffmann La Roche Metodo para la elaboracion de conjugados de la region fc de anticuerpos que comprenden por lo menos una entidad de union que se une especificamente a un objetivo y usos del mismo.
JP6203838B2 (ja) 2012-06-27 2017-09-27 エフ.ホフマン−ラ ロシュ アーゲーF. Hoffmann−La Roche Aktiengesellschaft 少なくとも2つの異なる結合実体を含む、テーラーメイドの高度に選択的かつ多重特異的なターゲティング実体を選択および作製するための方法、ならびにその使用
US20160075766A1 (en) * 2013-05-21 2016-03-17 Roche Diagnostics Operations, Inc. Method for producing antibodies using ovine b-cells and uses thereof
CN105612182B (zh) 2013-10-11 2019-12-10 豪夫迈·罗氏有限公司 多特异性结构域交换共有可变轻链抗体
CN105283543A (zh) * 2014-05-19 2016-01-27 豪夫迈·罗氏有限公司 使用绵羊b细胞产生抗体的方法及其用途
PL3227332T3 (pl) 2014-12-03 2020-06-15 F. Hoffmann-La Roche Ag Wielospecyficzne przeciwciała
ES2951698T3 (es) 2016-03-30 2023-10-24 Hoffmann La Roche Procedimiento de cultivo de linfocitos B
MX2019007356A (es) * 2016-12-23 2019-09-05 Visterra Inc Polipeptidos de union y metodos para fabricarlos.
JP6916884B2 (ja) 2017-01-02 2021-08-11 エフ.ホフマン−ラ ロシュ アーゲーF. Hoffmann−La Roche Aktiengesellschaft B細胞培養法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9815909D0 (en) 1998-07-21 1998-09-16 Btg Int Ltd Antibody preparation
CN100383244C (zh) * 2003-01-07 2008-04-23 西福根有限公司 用于生产重组多克隆蛋白质的方法
US20060051348A1 (en) 2004-09-09 2006-03-09 Jorn Gorlach Method of producing a plurality of isolated antibodies to a plurality of cognate antigens
CA2622603C (en) 2005-09-15 2014-06-17 Crucell Holland B.V. Method for preparing immunoglobulin libraries
CA2652392C (en) 2006-05-19 2017-10-10 Alder Biopharmaceuticals, Inc. Culture method for obtaining a clonal population of antigen-specific b cells
HUE043782T2 (hu) 2007-05-21 2019-09-30 Alderbio Holdings Llc IL-6 elleni antitestek és alkalmazásuk
WO2010056898A2 (en) * 2008-11-12 2010-05-20 University Of Maryland, Baltimore Rapid expression cloning of human monoclonal antibodies from memory b cells
US8609097B2 (en) * 2009-06-10 2013-12-17 Hoffmann-La Roche Inc. Use of an anti-Tau pS422 antibody for the treatment of brain diseases
US20120302738A1 (en) * 2009-11-16 2012-11-29 Acyte Biotech Pty Ltd Recombinant antibody vector
WO2011112566A2 (en) * 2010-03-11 2011-09-15 Abbott Laboratories Basigin binding proteins
SI2400298T1 (sl) 2010-05-28 2013-11-29 F. Hoffmann-La Roche Ag Postopek kultivacije posamezne B-celice in izdelava specifičnih protiteles
JP2015500655A (ja) * 2011-12-21 2015-01-08 エフ.ホフマン−ラ ロシュ アーゲーF. Hoffmann−La Roche Aktiengesellschaft 同起源の抗体可変領域遺伝子セグメントをクローニングおよび発現させるための迅速な方法

Also Published As

Publication number Publication date
MX354049B (es) 2018-02-09
BR112014013034A2 (pt) 2017-12-19
CN104011074A (zh) 2014-08-27
US20170210785A1 (en) 2017-07-27
US12024548B2 (en) 2024-07-02
KR20140104963A (ko) 2014-08-29
EP2794652A1 (en) 2014-10-29
WO2013092716A1 (en) 2013-06-27
JP2017221190A (ja) 2017-12-21
CN109810188A (zh) 2019-05-28
JP2019162144A (ja) 2019-09-26
MX2014007256A (es) 2014-08-01
CA2854243A1 (en) 2013-06-27
EP2794652B1 (en) 2017-11-15
RU2014128987A (ru) 2016-02-20
US20140302559A1 (en) 2014-10-09
US20190382469A1 (en) 2019-12-19
RU2612910C2 (ru) 2017-03-13
JP2015500655A (ja) 2015-01-08
SG11201403365TA (en) 2014-07-30
JP6573331B2 (ja) 2019-09-11

Similar Documents

Publication Publication Date Title
HK1199891A1 (zh) 用於克隆和表達關聯抗體可變區基因區段的快速方法
HK1252157A1 (zh) 重組病毒產品和抑制dux4表達的方法
IL231259A0 (en) A furnace with a high diagnosis and a method of operation
EP2691121A4 (en) COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF TMPRSS6 GENE
PL2752006T3 (pl) Sposób konstruowania listy scalania
ZA201309287B (en) Methods and compositions for selective regulation of protein expression
EP2662385A4 (en) METHOD FOR IMPROVING THE PHYSICAL PROPERTIES OF ANTIBODIES
GB201103450D0 (en) Apparatus and method of manipulation of articles
SG11201400405TA (en) Caninised antibodies and method for the production of same
HK1201537A1 (zh) 抗- 抗體和使用方法
IL228073A0 (en) Method for the determination of polysorbate
EP2745678A4 (en) PROCESS FOR CONTROLLING THE REPRODUCTION OF HOPPING
EP2699673A4 (en) RECOMBINANT VIRUS PRODUCTS AND METHODS FOR EXPRESSION INHIBITION OF MYOTILINE
LT2701707T (lt) Diskinezijos gydymo būdas
PL2663662T3 (pl) Sposób odsiarczania stali
ZA201306212B (en) An improved process for the preparation of voriconazole and intermediates thereof
EP2726652A4 (en) PROCESS FOR PROTEIN DISPLAY
GB2497108B (en) Laser system and associated method of operation
HK1184173A1 (zh) 抗- 抗體和使用方法
GB2487128B (en) Carton and method of assembly thereof
EP2774995A4 (en) METHOD OF MEASURING THE ABUNDANCE OF GENES
EP2707569A4 (en) DORN ARRANGEMENT AND OPERATING PROCEDURE THEREFOR
AU2011902463A0 (en) Method of Desulfurizing Steel
AU2011905262A0 (en) Method of blasting